Management of Mild to Moderate Facial Acne Vulgaris

Phase 4

Completed

• Conditions: Acne vulgaris,

• Registration Number: CTRI/2021/04/033182
• Lead Sponsor: Ashwini T

Brief Summary

After obtaining approval from the Institutional Ethics Committee, the study will be conducted in the Department of Dermatology, Sree Balaji Medical college & Hospital, Chrompet, Chennai.

Patients coming to Department of Dermatology, SBMCH with the history of acne will be subjected to thorough dermatological examination. Based on Indian clinical scoring system the diagnosis of mild to moderate acne vulgaris will be made. The patients who fulfil inclusion criteria will be recruited in the study. Informed consent will be obtained after explaining the risks and benefits in the treatment of acne vulgaris

Patients will be assessed at Baseline, 4 weeks, 8 weeks, 12weeks to assess the efficacy      based on lesion reduction. The Patients will be divided into two groups

**Group 1:** Patients taking topical adapalene gel 0.1%; Sample size: 50

**Group 2:** Patients taking topical benzoyl peroxide gel 2.5%; Sample size: 50

This study will be registered with Clinical Trials Registry of India

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-30
• Study Completion: 2022-03-30
• Last Update Posted: 2022-05-26

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients of both genders of age group between 13 to 40 years with mild to moderate facial acne vulgaris who are willing to participate in study were included.

Exclusion Criteria

Pregnancy and lactation Patient not willing to participate and not willing to come for follow-up Patients with drug induced acneiform eruptions Patients with history of allergy to adapalene and benzoyl peroxide Patients with pre-existing chronic systemic illness Patients with severe and cystic acne vulgaris.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Effects of Adapalene and Benzoyl Peroxide in terms of lesion reduction will be evaluated	Baseline,4weeks,8weeks,12weeks

Secondary Outcome Measures

Name	Time	Method
The side effects of Adapalene and Benzoyl peroxide will be assessed	Baseline,4weeks,8weeks,12weeks

Trial Locations

Locations (1)

Sree Balaji Medical College and Hospital; 🇮🇳 Kancheepuram, TAMIL NADU, India

Sree Balaji Medical College and Hospital

🇮🇳Kancheepuram, TAMIL NADU, India

Ashwini T

Principal investigator

7550078080

dr.t.ashwini@gmail.com